The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with ...

Merck's stock sank after the company reported fourth-quarter and year-end 2024 earnings this morning. Although it narrowly ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

Merck (MRK) reported fourth quarter and full-year earnings Tuesday, in line with Wall Street estimates. The bad news: Its ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

show he has earned more than $2.4 million from the Wisner Baum arrangement in recent years. Wisner Baum is currently suing Merck over Gardasil – which is administered to young people to prevent ...

The prominent anti-vaccine proponent was co-counsel with the law firm Wisner Baum in suing Merck over allegations that Gardasil caused life-altering injury to young men and women. In his letter to ...

In an ethics agreement published on Wednesday, Kennedy said he would keep his share of potential winnings from the case brought by law firm Wisner Baum against Merck’s Gardasil vaccine ...

chief Pentagon spokesman Top 10 greatest keyboard players of all time Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook Cooper Kupp Announces He’s ...

Its strong business performance with 7% YoY revenue growth, driven by Keytruda and GARDASIL expansions ... which saw 21% YoY FX-neutral sales growth to $7.4 billion, and by Animal Health sale ...